Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Rheumatology

Why Are Preventative Antibiotics Prescribed for GPA?

At a Glance

Preventative antibiotics are prescribed for Granulomatosis with polyangiitis (GPA) to protect against severe lung infections like PJP. Because GPA treatments suppress your immune system, these antibiotics act as a vital shield until your steroid doses are safely reduced.

In this answer

4 sections

01

Protecting Your Weakened Immune System

02

Guarding Against PJP

03

Why Take It Regularly?

04

What to Watch For

You are prescribed a preventative antibiotic—usually trimethoprim-sulfamethoxazole (commonly known as Bactrim or Septra)—not to treat Granulomatosis with polyangiitis (GPA) itself, but to protect you from severe infections while your immune system is suppressed by GPA treatments.

Protecting Your Weakened Immune System

When you have GPA, your immune system mistakenly attacks your own blood vessels. To stop this damage, doctors prescribe powerful immunosuppressive medications, such as rituximab, cyclophosphamide, or high-dose corticosteroids (like prednisone). While these drugs are essential and highly effective at controlling GPA, they also severely suppress your body’s natural ability to fight off everyday germs [1][2].

Because your immune system is temporarily “turned down,” you become vulnerable to opportunistic infections—infections caused by common organisms that wouldn’t normally make a healthy person sick.

Guarding Against PJP

The primary reason you are taking this antibiotic is to prevent a specific, life-threatening lung infection called Pneumocystis jirovecii pneumonia (PJP) [3][4]. Pneumocystis jirovecii is a fungus commonly found in the environment. A healthy immune system can easily fight it off, but for people taking intense immunosuppressants for GPA, it can cause severe and dangerous pneumonia [5]. While this antibiotic provides some protection against other common bacterial infections, its main purpose is to shield you from PJP [1].

The American College of Rheumatology strongly recommends preventative antibiotics—a practice called prophylaxis—for GPA patients undergoing intense therapy to prevent PJP [3]. The most commonly prescribed antibiotic for this is trimethoprim-sulfamethoxazole [2].

Why Take It Regularly?

Taking a low dose of this antibiotic daily (or sometimes three times a week) provides a continuous shield against PJP while your immune system is most compromised. Research shows that this preventative measure is highly effective [6] and significantly reduces the risk of serious bloodstream infections [7][1]. It has also been shown to reduce overall mortality in patients with rheumatic diseases who are taking high-dose steroids [8][9].

You will not necessarily need to take this medication forever. While the exact timeline depends on your individual treatment plan [10][11], doctors typically recommend stopping the antibiotic once your high-dose steroid treatment is tapered down to a lower, safer level.

What to Watch For

While this preventative antibiotic is generally safe and highly recommended for most people, it can cause side effects or interact with other medications [12]. Because it is often taken alongside other powerful drugs, your care team will monitor you closely. Be sure to drink plenty of water while taking this medication to protect your kidneys, and watch for the following:

  • Medication Interactions: Never take this antibiotic with methotrexate (another medication sometimes used for GPA) without strict doctor supervision. Combining them can cause dangerously low blood counts. Always ensure your care team knows every medication you take.
  • Low blood cell counts (myelotoxicity): Your doctor will monitor this through blood tests [12][13], but you should watch for physical signs like unexplained bruising, unusual fatigue, or a sudden fever.
  • High potassium levels (hyperkalemia): This is monitored via lab work [14], but let your doctor know if you experience new muscle cramps or weakness.
  • Sun Sensitivity: This medication can make your skin much more sensitive to the sun (photosensitivity). Be sure to wear sunscreen and protective clothing when outdoors.
  • Allergic reactions: Watch for severe skin rashes or hives, especially if you have a known allergy to “sulfa” drugs.

If you are allergic to sulfa drugs or experience uncomfortable side effects, your doctor can prescribe alternative preventative medications—such as dapsone or atovaquone—or try desensitization techniques to keep you protected [15][16]. Never stop taking your preventative antibiotic without speaking to your rheumatologist first, as doing so could leave you vulnerable to a severe lung infection.

Common questions in this guide

Why do I need to take Bactrim or Septra for GPA?
The primary reason is to prevent Pneumocystis jirovecii pneumonia (PJP), a severe and potentially life-threatening fungal lung infection that can occur when your immune system is heavily suppressed by GPA treatments.
How long will I need to take preventative antibiotics for GPA?
You typically will not need to take them forever. Doctors usually recommend stopping the antibiotic once your high-dose steroid treatment is tapered down to a lower, safer level.
Can I take methotrexate with my preventative antibiotic?
You should never take trimethoprim-sulfamethoxazole with methotrexate without strict doctor supervision. Combining these two medications can cause dangerously low blood cell counts.
What if I have a sulfa allergy but need preventative antibiotics for GPA?
If you have a sulfa allergy, your doctor can prescribe alternative preventative medications like dapsone or atovaquone. They may also try desensitization techniques to safely protect you from infection.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How long will I need to stay on this preventative antibiotic, and will I be able to stop it once my steroid dose is lowered?
  2. 2.Are there any physical side effects or symptoms I should contact you about immediately between my scheduled blood tests?
  3. 3.Since I am taking this daily antibiotic, how often will you be checking my blood counts and potassium levels?
  4. 4.I understand this primarily protects me from PJP, but does it also lower my risk for other common infections, or should I be taking additional precautions?
  5. 5.Are any of the other medications I am taking, such as methotrexate, potentially dangerous to mix with this antibiotic?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Are Lung Nodules in GPA Cancerous?Can Avacopan Replace Prednisone for GPA Treatment?Can You Get Pregnant With Granulomatosis With Polyangiitis?How to Manage Anxiety and Fear of Relapse in GPAIs It a GPA Flare or Just a Cold? How to TellWhat is Pauci-Immune Glomerulonephritis in GPA?What is the Best Diet and Lifestyle for Managing GPA?What is the Difference Between Limited and Systemic GPA?What is the Life Expectancy and Survival Rate for GPA?Does Granulomatosis with Polyangiitis Cause Blood Clots?Why Was Wegener's Granulomatosis Changed to GPA?

References

References (16)
  1. 1

    Reduction of Pneumocystis jirovecii pneumonia and bloodstream infections by trimethoprim-sulfamethoxazole prophylaxis in patients with rheumatic diseases.

    Honda N, Tagashira Y, Kawai S, et al.

    Scandinavian journal of rheumatology 2021; (50(5)):365-371 doi:10.1080/03009742.2020.1850854.

    PMID: 33749507
  2. 2

    Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.

    Herrou J, De Lastours V

    Annals of the rheumatic diseases 2020; (79(2)):e23 doi:10.1136/annrheumdis-2018-214718.

    PMID: 30487148
  3. 3

    Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab Users.

    Wallace ZS, Putman M

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(11)):1904-1906 doi:10.1002/art.42562.

    PMID: 37192270
  4. 4

    Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?

    Wolfe RM, Peacock JE

    Current rheumatology reports 2017; (19(6)):35 doi:10.1007/s11926-017-0664-6.

    PMID: 28488228
  5. 5

    Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.

    Ghembaza A, Vautier M, Cacoub P, et al.

    Chest 2020; (158(6)):2323-2332 doi:10.1016/j.chest.2020.05.558.

    PMID: 32502592
  6. 6

    The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.

    Messiaen PE, Cuyx S, Dejagere T, van der Hilst JC

    Transplant infectious disease : an official journal of the Transplantation Society 2017; (19(2)) doi:10.1111/tid.12651.

    PMID: 28035717
  7. 7

    Trimethoprim sulfamethoxazole prophylaxis and serious infections in granulomatosis with polyangiitis treated with rituximab.

    Mendel A, Behlouli H, Vinet É, et al.

    Rheumatology (Oxford, England) 2025; (64(4)):2041-2049 doi:10.1093/rheumatology/keae368.

    PMID: 39024050
  8. 8

    Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.

    Avino LJ, Naylor SM, Roecker AM

    The Annals of pharmacotherapy 2016; (50(8)):673-9 doi:10.1177/1060028016650107.

    PMID: 27242349
  9. 9

    Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.

    Park JW, Curtis JR, Moon J, et al.

    Annals of the rheumatic diseases 2018; (77(5)):644-649 doi:10.1136/annrheumdis-2017-211796.

    PMID: 29092853
  10. 10

    Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.

    Werbel WA, Ison MG, Angarone MP, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2018; (20(3)):e12876 doi:10.1111/tid.12876.

    PMID: 29512868
  11. 11

    Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study.

    Mendel A, Behlouli H, de Moura CS, et al.

    Arthritis research & therapy 2023; (25(1)):133 doi:10.1186/s13075-023-03114-7.

    PMID: 37516897
  12. 12

    Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.

    Chen RY, Li DW, Wang JY, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022; (125()):209-215 doi:10.1016/j.ijid.2022.10.004.

    PMID: 36243280
  13. 13

    Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia.

    Du Plooy N, Rayner B

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2019; (109(2)):89-90 doi:10.7196/SAMJ.2019.v109i2.13660.

    PMID: 30834857
  14. 14

    Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation.

    Lipsitt A, Hijano DR, Ferrolino JA, et al.

    Pediatric blood & cancer 2024; (71(10)):e31201 doi:10.1002/pbc.31201.

    PMID: 39010649
  15. 15

    Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.

    Kitazawa T, Seo K, Yoshino Y, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019; (25(5)):351-354 doi:10.1016/j.jiac.2019.01.005.

    PMID: 30711257
  16. 16

    Impact of prophylaxis choice on risk of pneumocystis pneumonia in children with cancer: A case-control study.

    Geerlinks AV, Campigotto A, Science M, Gupta S

    European journal of cancer (Oxford, England : 1990) 2020; (140()):71-75 doi:10.1016/j.ejca.2020.09.013.

    PMID: 33059195

This page explains the use of preventative antibiotics in GPA treatment for educational purposes only. Always consult your rheumatologist or care team before changing or stopping any of your medications.

Get notified when new evidence is published on Granulomatosis with polyangiitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.